Clinical Trial Update: Steroid Sparing in Immune Related Hepatitis (irH) [NA]

View source ↗

Summary

This clinical trial is currently recruiting to evaluate a steroid-sparing strategy for immune-related hepatitis, sponsored by AHS Cancer Control Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune-related Hepatitis

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Hepatitis Immune | NA | Status: RECRUITING